Announcements Trials
Browse Landscape

Phase

Phase NA 24Phase 2 20Phase 3 12Phase 1/2 7Phase 4 5Phase 1 5Phase EARLY_PHASE1 3Phase 2/3 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 2Breast Cancer Female 1

Interventions

Magnetic Resonance Spectroscopy 59Cyclophosphamide 44pembrolizumab 34Radiotherapy 30fludarabine 27Nivolumab 26Biopsy 26Metformin 22Fluorodeoxyglucose F18 22Specimen Handling 20Bevacizumab 20Temozolomide 17Radiosurgery 17Cisplatin 16Carboplatin 14Fluorouracil 13Dexamethasone 13Paclitaxel 12Gemcitabine 12Etoposide 12gallium 68 PSMA-11 11durvalumab 11X-Rays 11Surgical Procedures, Operative 11Radiation 11Positron Emission Tomography Computed Tomography 11Letrozole 11Irinotecan 11Ipilimumab 11Surveys and Questionnaires 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × Vitamin D × Clear all
NCT03629717 2024-10-16

RANKL Inhibition and Breast Tissue Biomarkers

Washington University School of Medicine

Phase EARLY_PHASE1 Completed
10 enrolled
Breast

Breast Neoplasms

NCT05331807 2024-05-08

Omega-3 and Vitamin D Supplementation in Breast Cancer Women

Universiti Sains Malaysia

Phase EARLY_PHASE1 Completed
88 enrolled
Breast

Breast Cancer Female

NCT00263185 2014-09-22

High Dose Vit D Musculoskeletal Symptoms & Bone Density in Anastrozole-Treated Breast Cancer With Marginal Vit D Status

Washington University School of Medicine

Phase EARLY_PHASE1 Completed
63 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡